Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide

Glypican-3 (GPC3), which is a carcinoembryonic antigen, is overexpressed in human hepatocellular carcinoma (HCC). Previously, we performed a phase I clinical trial of GPC3-derived peptide vaccination in patients with advanced HCC, and reported that GPC3 peptide vaccination is safe and has clinical e...

Descripción completa

Detalles Bibliográficos
Autores principales: TADA, YOSHITAKA, YOSHIKAWA, TOSHIAKI, SHIMOMURA, MANAMI, SAWADA, YU, SAKAI, MAYUKO, SHIRAKAWA, HIROFUMI, NOBUOKA, DAISUKE, NAKATSURA, TETSUYA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 201
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829797/
https://www.ncbi.nlm.nih.gov/pubmed/23903757
http://dx.doi.org/ 10.3892/ijo.2013.2044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829797/
https://www.ncbi.nlm.nih.gov/pubmed/23903757
http://dx.doi.org/ 10.3892/ijo.2013.2044

Ejemplares similares